Fredun Pharmaceuticals Complete Financial Statements
In FY2025, Fredun Pharmaceuticals (FREDUN) reported revenue ₹144 Cr, net profit ₹9 Cr and EPS ₹19.98, with a net profit margin of 6.3% and ROE of 6.4%. Full financial statements from FY2024 to FY2025 (2 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore FREDUN fundamental worth to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
FREDUN Revenue, Net Profit & EBITDA — Year-on-Year Growth
FREDUN YoY (Sept 2024 vs Sept 2025). Review FREDUN earnings multiple to evaluate earnings-based valuation against sector peers.
FREDUN Income Statement — Revenue, EBITDA & Net Profit
Fredun Pharmaceuticals revenue ₹144 Cr, EBITDA ₹21 Cr, net profit ₹9 Cr, EPS ₹19.98 (2025) — net profit margin 6.3%. For live price, earnings ratios and company overview, see Fredun Pharmaceuticals stock price NSE.
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Jun 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 144 | 165 | 119 | 160 | 0 | 0 | 286 |
| Expenses | 123 | 150 | 103 | 135 | 0 | 0 | 251 |
| EBITDA | 21 | 15 | 17 | 25 | 0 | 0 | 35 |
| Operating Profit Margin % | 14.00% | 9.00% | 14.00% | 16.00% | 0.00% | 0.00% | 12.00% |
| Depreciation | 2 | 2 | 1 | 2 | 0 | 0 | 3 |
| Interest | 8 | 8 | 7 | 11 | 0 | 0 | 14 |
| Profit Before Tax | 13 | 7 | 9 | 14 | 0 | 0 | 20 |
| Tax | 3 | 1 | 2 | 4 | 0 | 0 | 7 |
| Net Profit | 9 | 6 | 7 | 11 | 0 | 0 | 14 |
| Earnings Per Share (₹) | 19.98 | 12.71 | 14.33 | 22.19 | 0.00 | 0.00 | 29.09 |
FREDUN Balance Sheet — Assets, Liabilities & Shareholders' Equity
FREDUN total assets ₹487 Cr, total equity ₹141 Cr, total liabilities ₹ Cr (2025) — ROE 6.4%.
| Particulars | 2025 |
|---|---|
| ASSETS | |
| Total Assets | 487 |
| Current Assets | 428 |
| Fixed Assets | 53 |
| Capital Work in Progress | 0 |
| Investments | 2 |
| Other Assets | 433 |
| LIABILITIES | |
| Total Liabilities | |
| Current Liabilities | 18 |
| Non-Current Liabilities | |
| SHAREHOLDERS' EQUITY | |
| Total Equity | 141 |
| Share Capital | 5 |
| Reserves & Surplus | 136 |
FREDUN Cash Flow Statement — Operating, Investing & Financing
Fredun Pharmaceuticals operating cash flow ₹-29 Cr, investing ₹-6 Cr, financing ₹39 Cr, net cash flow ₹4 Cr (2025).
| Particulars | March 2025 |
|---|---|
| Operating Activities | -29 |
| Investing Activities | -6 |
| Financing Activities | 39 |
| Net Cash Flow | 4 |